Previewing the 2024 ESMO Congress with oncology watcher Bertrand Delsuc

HSBC's Rajesh Kumar joins BiotechTV for Analyst Thursdays and talks PD-1xVEGF, obesity, European conglomerates, and more

Biotech expert Dirk Haussecker shares his opinion on the various emerging technology platforms in genetic medicine

Paris Saclay Cancer Cluster is designed to support entrepreneurs and create an innovation ecosystem of oncology R&D right at Gustave Roussy

With decades of experience, Sofinnova Partners' Chairman and Managing Partner Antoine Papiernik shares his thoughts on investing in life sciences and Europe

The co-founder of InFocus Therapeutics describes being a biotech entrepreneur in Paris, and how the Paris Saclay Cancer Cluster might help

Dr. Scott Solomon, PI of Bayer's FINEARTS-HF study of KERENDIA, discusses using this non-steroidal MRA in heart failure at the ESC Congress

Dr. Marianna Fontana, primary investigator of HELIOS-B, discusses the full study results presented at the European Society of Cardiology Congress

Wrapping up the summer and looking ahead to biotech's post Labor Day news flow with NYSE's Eric Dimise from Kendall Square

Health 2035 Summit: Investor Martin Alexander Gershon describes how technology has played an increasingly central role in his investment focus

Health 2035 Summit: Kristen Dahlgren, founder and CEO of the Cancer Vaccine Coalition, discusses vaccines for breast cancer and beyond

Kicking off the Health 2035 Summit in New York with co-hosts Katherine Andersen of HSBC Innovation Banking and Hamid Ghanadan of LINUS

Health 2035 Summit: Luke Timmerman recaps last week's Timmerman Traverse charity climb in the Cascades, and more

Dr. Maha Radhakrishnan, former Biogen CMO, joined Sofinnova Investments this week as Executive Partner

Oppenheimer analyst Jay Olson joins BiotechTV for Analyst Thursdays and talks obesity and earnings

Jefferies' SVP Andrew Tsai joins BiotechTV for Analyst Thursdays and talks neuro names and more

AI x Bio Summit: Bessemer Venture Partners' Morgan Cheatham shares his take on AI in life sciences

The Co-Hosts of the AI x Bio Summit at NYSE talk about the conference and their take on AI

The Co-Founder and CEO of Philadelphia based BioPhy describes how he sees AI playing out across the biopharma landscape

Stifel's Paul Matteis joins BiotechTV for Analyst Thursdays from Boston